{"text": ["Lilly", "Declares", "Second-Quarter", "2018", "Dividend"], "created_at": "2018-05-07 19:15:00"}
{"text": ["What's", "in", "Store", "for", "Radius", "Health", "(RDUS)", "in", "Q1", "Earnings?"], "created_at": "2018-05-07 15:37:31"}
{"text": ["What's", "in", "Store", "for", "Radius", "Health", "(RDUS)", "in", "Q1", "Earnings?"], "created_at": "2018-05-07 15:37:31"}
{"text": ["Alimta:", "An", "Emerging", "Drug", "to", "Treat", "Lung", "Cancer"], "created_at": "2018-05-07 15:15:02"}
{"text": ["Allergan\u2019s", "Valuations", "after", "Its", "1Q18", "Earnings"], "created_at": "2018-05-07 14:32:12"}
{"text": ["Verzenio:", "Major", "CDK4/6", "Inhibitor", "in", "the", "Future"], "created_at": "2018-05-07 13:45:03"}
{"text": ["Taltz:", "Therapy", "for", "Psoriasis", "Indication"], "created_at": "2018-05-07 12:12:48"}
{"text": ["How", "Celgene", "Performed", "in", "1Q18"], "created_at": "2018-05-07 12:07:08"}
{"text": ["See", "what", "the", "IHS", "Markit", "Score", "report", "has", "to", "say", "about", "Eli", "Lilly", "And", "Co."], "created_at": "2018-05-07 12:00:52"}
{"text": ["Allergan\u2019s", "US", "General", "Medicines", "Segment", "in", "1Q18"], "created_at": "2018-05-07 11:34:19"}
